NIH· @NIH · X·· 4 小时前AI 评分22
AI 导读
一项由NIH支持的新临床前研究探索了一种口服纳米药物，旨在帮助抗癌免疫细胞保持更长时间的活性。 在小鼠模型中，该疗法改善了免疫治疗应答并减缓了肿瘤生长。 了解更多：https://bit.ly/4jFBmUK
正文
A new NIH-supported preclinical study explores an oral nanomedicine designed to help cancer-fighting immune cells stay active longer.
In mouse models, the treatment improved responses to immunotherapy and slowed tumor growth.
Learn more: https://bit.ly/4jFBmUK
来源：NIH · x.com